Attached files

file filename
10-K - FORM 10-K - ANADYS PHARMACEUTICALS INCa58867e10vk.htm
EX-23.1 - EX-23.1 - ANADYS PHARMACEUTICALS INCa58867exv23w1.htm
EX-31.2 - EX-31.2 - ANADYS PHARMACEUTICALS INCa58867exv31w2.htm
EX-31.1 - EX-31.1 - ANADYS PHARMACEUTICALS INCa58867exv31w1.htm
EX-10.21 - EX-10.21 - ANADYS PHARMACEUTICALS INCa58867exv10w21.htm
EX-10.19 - EX-10.19 - ANADYS PHARMACEUTICALS INCa58867exv10w19.htm
EX-10.23 - EX-10.23 - ANADYS PHARMACEUTICALS INCa58867exv10w23.htm
EX-10.20 - EX-10.20 - ANADYS PHARMACEUTICALS INCa58867exv10w20.htm
EX-10.22 - EX-10.22 - ANADYS PHARMACEUTICALS INCa58867exv10w22.htm
         
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND VICE PRESIDENT, FINANCE AND OPERATIONS
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 906 of the Public Company Accounting Reform and Investor Protection Act of 2002 (18 U.S.C. Section 1350, as adopted), Stephen T. Worland, Ph.D., as President and Chief Executive Officer of the Company, and Peter T. Slover, as Vice President, Finance and Operations of the Company, each hereby certifies that, to the best of his or her knowledge:
     1. The Company’s Annual Report on Form 10-K for the year ended December 31, 2010, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
     2. The information contained in the Annual Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Annual Report and results of operations of the Company for the periods covered by the Annual Report.
     
/s/ Stephen T. Worland
  /s/ Peter T. Slover
 
   
Stephen T. Worland, Ph.D.
President and Chief Executive Officer
Date: March 4, 2011
  Peter T. Slover
Vice President, Finance and Operations
Date: March 4, 2011